Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Catalyst Pharma (CPRX – Research Report), Ascendis Pharma (ASND – Research Report) and Avanos ...

NEW YORK, April 21, 2025 (GLOBE NEWSWIRE) -- The board of directors of Royalty Pharma plc (Nasdaq: RPRX) has approved the payment of a dividend for the second quarter of 2025 of $0.22 per Class A ...

The Trump administration’s threat of pharmaceutical tariffs could risk significant political backlash, as the drug industry and outside experts are raising red flags over worsening shortages and ...

Donald Trump's desire to persecute pharma companies with his illogical and unjustifiable tariffs is a particular threat to the UK. Life sciences is one of the areas in which the country still ...

Buy SBI May Futures in the range of Rs 820–800. Sun Pharmaceutical has seen long liquidation throughout its uptrend, and the cumulative open interest has now dropped to its lowest level in six ...

Destiny Pharma has joined a growing list of UK biotechs seeking to delist from the Alternative Investments Market (AIM) and return to private ownership. The Brighton-based company, which will put ...

Pharma stocks rally on Trump's tariff pause, led by up to 7% surge in Laurus Labs, Granules, Cipla Apr 11 2025 05:21 PM Stocks to Watch Today: TCS, Biocon, GAIL, Greaves Cotton, Sun Pharma ...

In 2025, pharma companies must enable an instantaneous data-to-decision value chain that is AI-powered, cloud-based, and product-enabled. You need to ingest data rapidly, manage it, keep it ...

April 07, 2025 (GLOBE NEWSWIRE) -- Verrica Pharmaceuticals Inc. (“Verrica” or the “Company”) (Nasdaq: VRCA), a dermatology therapeutics company developing medications for skin WEST CHESTER ...

ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of medicines for central nervous system (CNS) disorders and rare diseases in the United ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Petros Pharmaceuticals ( NASDAQ:PTPI ) Full Year 2024 Results Key Financial Results Revenue: US$5.11m (down 12% from FY... Company to integrate industry leading big data technology solutions into ...